Login / Signup

Serum Amyloid a Predicts Prognosis and Chemotherapy Efficacy in Patients with Advanced Pancreatic Cancer.

Honglu DingQiuxia YangYize MaoDailei QinZehui YaoRuiqi WangTao QinShengping Li
Published in: Journal of inflammation research (2023)
Owing to the rapid and simple analysis of peripheral blood, baseline SAA might be a useful clinical biomarker, not only as a prognostic biomarker for patients with APC, but also as a guide for the selection of chemotherapy regimens.
Keyphrases
  • peripheral blood
  • locally advanced
  • squamous cell carcinoma
  • radiation therapy
  • chemotherapy induced